Comments

VYNE Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does VYNE Therapeutics (VYNE) operate in?

VYNE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

VYNENASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$1.04

0.044.00%

At close: -

$1.06

0.021.92%

After Hours: May 23, 5:25 PM EDT

VYNE Therapeutics (VYNE) Forecast

News Earnings VYNE Therapeutics (VYNE) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

VYNE Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:VYNE | Benzinga

Explore VYNE Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VYNE.

Open	$0.98
Close	$1.04
Volume / Avg.	1.33M / 188.31K
Day Range	$0.96 - $1.08
52 Wk Range	0.99 - 4.30
Market Cap	$17.66M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	31
Short Interest	1.32%
Days to Cover	1

Recent News

FDA Puts VYNE Therapeutics Early-Stage Psoriasis Study On Hold

VYNE pauses VYN202 psoriasis trial after FDA clinical hold tied to animal toxicity data; separate vitiligo trial remains on track for mid-2025 results.

Vandana Singh

Why Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Top 4 Health Care Stocks That May Rocket Higher In Q1

The most oversold stocks in the health care presents an opportunity to buy into undervalued companies.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Jan

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.98
Close	$1.04
Volume / Avg.	1.33M / 188.31K
Day Range	$0.96 - $1.08
52 Wk Range	0.99 - 4.30
Market Cap	$17.66M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	31
Short Interest	1.32%
Days to Cover	1

About VYNE Therapeutics Inc

Sector

Health Care

Industry

Pharmaceuticals

VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative a...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy VYNE Therapeutics (VYNE) stock?

You can purchase shares of VYNE Therapeutics (NASDAQ:VYNE) through any online brokerage.

View our list of the best stock brokerages

Who are VYNE Therapeutics (VYNE) competitors?

Other companies in VYNE Therapeutics’s space includes: Cingulate (NASDAQ:CING), Gelteq (NASDAQ:GELS), Cocrystal Pharma (NASDAQ:COCP), Kiora Pharmaceuticals (NASDAQ:KPRX) and CalciMedica (NASDAQ:CALC).

What is the forecast, or price target, for VYNE Therapeutics (VYNE) stock?

VYNE Therapeutics has a consensus price target of $7.17.

What is the current price for VYNE Therapeutics (VYNE)?

The stock price for VYNE Therapeutics (NASDAQ: VYNE) is $1.06 last updated May 23, 2025 at 5:25 PM EDT.

Does VYNE Therapeutics (VYNE) pay a dividend?

There are no upcoming dividends for VYNE Therapeutics.

When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?

VYNE Therapeutics’s Q2 earnings are confirmed for Wednesday, August 13, 2025.

Is VYNE Therapeutics (VYNE) going to split?

There is no upcoming split for VYNE Therapeutics.

What sector and industry does VYNE Therapeutics (VYNE) operate in?

VYNE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.